Word

AMBIXAVEL

Status

Registered

Status Code

700

Status Date

Tuesday, July 20, 2021

Serial Number

79299895

Registration Number

6422527

Registration Date

Tuesday, July 20, 2021

Mark Type

4000

Filing Date

Wednesday, October 28, 2020

Published for Opposition

Tuesday, May 4, 2021

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events

Jul 19, 2023

Change Of Name/Address Rec'd From Ib

Sep 25, 2021

Notification Processed By Ib

Sep 8, 2021

Final Disposition Notice Sent To Ib

Sep 8, 2021

Final Disposition Processed

Aug 19, 2021

Grant Of Protection Created, To Be Sent To Ib

Jul 20, 2021

Registered-Principal Register

May 4, 2021

Published For Opposition

May 3, 2021

Notification Processed By Ib

Apr 14, 2021

Notification Of Possible Opposition Sent To Ib

Apr 14, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 14, 2021

Notice Of Publication

Mar 30, 2021

Approved For Pub - Principal Register

Mar 30, 2021

Assigned To Examiner

Feb 18, 2021

Correction From The Ib Examined, No Action Is Needed

Feb 13, 2021

Correction Transaction Received From Ib

Jan 15, 2021

Application Filing Receipt Mailed

Jan 11, 2021

New Application Office Supplied Data Entered

Jan 7, 2021

Limitation From Original Application Entered

Dec 17, 2020

Sn Assigned For Sect 66a Appl From Ib